Hedera Dx News

Hedera Dx Secures €15 Million Series A to bring modern cancer care to patients across the globe

Hedera Dx Announces Publication of International, Multicenter, Pan-Cancer Liquid Biopsy Test Panel Analytical Validation in medRxiv

Hedera Dx Expects Increased Liquid Biopsy Adoption With Real-World Data Cancer Registries

Positive clinical progress in the biotech scene

Hedera Dx Launches AI-Enabled RWD Capabilities with First Patients Recruited in EMPATHY NSCLC: a Prospective, International, Decentralized, Multicenter, Real-World Utility Study for Liquid Biopsy

Liquid biopsies: minimally invasive cancer care